Anti-PM/Scl-100 Ab (RDL)
Also known as: PM Scler, PM/SCL, PM/SCL100
Use
The anti-PM/Scl-100 antibody is associated with younger age, calcinosis and has lower rates of gastrointestinal symptoms, ILD and pulmonary hypertension. There is also evidence of a possibly better survival compared to the presence of either anti-PM/Scl-75 or anti-Scl-70 antibodies.
Special Instructions
This test is a component of several profiles including Interstitial Lung Disease Panel I and II, Myomarker 3 Profile, Myomarker 3 Plus Profile, and Scleroderma Comprehensive Profile.
Limitations
This test was developed and its performance characteristics were determined by LabCorp. It has not been cleared or approved by the Food and Drug Administration.
Methodology
Immunoassay (ELISA)
Biomarkers
LOINC Codes
- 101221-0
- 101221-0
Result Turnaround Time
5-7 days
Related Documents
For more information, please review the documents below
Specimen
Serum
Volume
1 mL
Minimum Volume
0.3 mL
Container
Red-top tube or gel-barrier tube
Collection Instructions
Separate serum from cells within one hour of collection. Transfer to a plastic transport tube before shipping.
Storage Instructions
Refrigerate or freeze.
Causes for Rejection
Grossly hemolyzed; bacterial contamination; lipemic specimen; icteric specimen; non-serum specimen types
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 7 days |
| Refrigerated | 14 days |
| Frozen | 60 days |